Rating #67
Jim Simons
Renaissance Technologies
Portfolio value
Stocks
Performance
1 Year
+17.95%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Jim Simons’ Portfolio: Q1 2026
Top10 stocks: 11.19% of the portfolio
Jim Simons’ Trades: Q1 2026
Adds
New Buys
Sold Outs
Cuts
1.22ppt
0.44ppt
0.38ppt
0.40ppt
0.32ppt
0.26ppt
0.24ppt
0.15ppt
0.23ppt
V
Share Count Chg. (%)
Add +100.00%
0.22ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  AAPL | Add +100.00% | $260.25 | $800.43M | 1.22ppt | |
2  NVDA | Add +189.98% | $183.46 | $303.72M | 0.44ppt | |
3  AVGO | Add +89191.00% | $329.05 | $260.91M | 0.38ppt | |
4  LIN | Add +394.75% | $471.81 | $237.09M | 0.40ppt | |
5  JPM | Add +32662.97% | $303.48 | $208.26M | 0.32ppt | |
6  B | Add +335.76% | $46.26 | $195.20M | 0.26ppt | |
7  MELI | Add +337.08% | $1929.04 | $179.00M | 0.24ppt | |
8  MSTR | Add +122.59% | $142.95 | $167.76M | 0.15ppt | |
9  META | Add +100.00% | $640.86 | $162.38M | 0.23ppt | |
10 V SMH | Add +100.00% | $397.07 | $146.71M | 0.22ppt |
Jim Simons’ Holdings: Q1 2026
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1  UTHR | Pharmaceutical Pres | $129.79 | Cut -6.40% | 1.79M | $1.06B | 1.66% 0.21ppt | 4.03% | 80 Quarters | Q1 2026 | |
2  PLTR | Prepackaged Software | $17.95 | Cut -20.58% | 6.99M | $1.02B | 1.60% -0.83ppt | 0.29% | 20 Quarters | Q1 2026 | |
3 AAPL | Electronic Computers | $253.79 | Add +100.00% | 3.08M | $780.57M | 1.22% 1.22ppt | 0.02% | 32 Quarters | Q1 2026 | |
4  KGC | Gold & Silver Mining | $5.38 | Add +2.29% | 25.55M | $779.68M | 1.22% 0.13ppt | 2.11% | 53 Quarters | Q1 2026 | |
5  MU | Semiconductors | $238.37 | Cut -28.17% | 2.16M | $730.74M | 1.14% -0.19ppt | 0.19% | 3 Quarters | Q1 2026 | |
6  VRSN | Computer Programming Services | $122.51 | Add +1.40% | 2.82M | $699.92M | 1.09% 0.05ppt | 3.05% | 70 Quarters | Q1 2026 | |
7  EXEL | Biological products | $22.38 | Cut -1.34% | 13.73M | $588.75M | 0.92% -0.03ppt | 5.05% | 42 Quarters | Q1 2026 | |
8  FNV | Gold & Silver Mining | $100.07 | Cut -10.46% | 2.22M | $548.18M | 0.86% 0.06ppt | 1.15% | 49 Quarters | Q1 2026 | |
9  SNDK | Computer Storage | $128.06 | Cut -33.87% | 799.57K | $508.00M | 0.79% 0.35ppt | 0.54% | 4 Quarters | Q1 2026 | |
10 NVDA | Semiconductors | $163.89 | Add +189.98% | 2.53M | $440.70M | 0.69% 0.44ppt | 0.01% | 13 Quarters | Q1 2026 | |
11  CVX | Petroleum Refining | $154.79 | Cut -8.03% | 2.02M | $416.98M | 0.65% 0.13ppt | 0.11% | 9 Quarters | Q1 2026 | |
12  RBLX | Prepackaged Software | $64.61 | Add +7.51% | 7.13M | $403.05M | 0.63% -0.20ppt | 1.02% | 20 Quarters | Q1 2026 | |
13  CVNA | Retail-Auto Dealers & Gas | $316.50 | Cut -14.65% | 1.20M | $377.64M | 0.59% -0.33ppt | 0.85% | 11 Quarters | Q1 2026 | |
14  W | Retail-Catalog & Mail-Order | $60.23 | Cut -8.04% | 4.97M | $373.98M | 0.59% -0.26ppt | 3.82% | 17 Quarters | Q1 2026 | |
15  HOOD | Security Brokers & Dealers | $64.80 | Add +48.56% | 5.10M | $353.72M | 0.55% -0.05ppt | 0.57% | 17 Quarters | Q1 2026 | |
16  INCY | Physical & Biological Research | $80.22 | Cut -8.21% | 3.65M | $343.68M | 0.54% -0.07ppt | 1.87% | 34 Quarters | Q1 2026 | |
17  AGX | Specialty Trade Contractors | $81.25 | Add +2.05% | 610.90K | $332.73M | 0.52% 0.23ppt | 4.40% | 63 Quarters | Q1 2026 | |
18  INTC | Semiconductors | $31.89 | Cut -25.18% | 7.40M | $326.54M | 0.51% -0.06ppt | 0.15% | 6 Quarters | Q1 2026 | |
19  NBIX | Biological products | $118.53 | Add +8.04% | 2.42M | $318.67M | 0.50% 0.01ppt | 2.43% | 34 Quarters | Q1 2026 | |
20  UNH | Medical Service Plans | $299.72 | Add +45.39% | 1.16M | $313.46M | 0.49% 0.08ppt | 0.13% | 10 Quarters | Q1 2026 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.